Other Titles
Pediatric pain management
Abstract
Purpose: We previously published that a single dose of oral sucrose significantly increased plasma markers of adenosine triphosphate (ATP) utilization (hypoxanthine) and oxidative stress (xanthine, allantoin) in neonates undergoing a clinically required heel lance [1,2]. However, the effect of repeated doses of sucrose and other sweet solutions such as glucose on above markers is unknown.
Methods: Using a prospective randomized double blind clinical trial, we measured urinary markers of ATP utilization and oxidative stress in preterm neonates over days of life 3-7. Subjects were preterm neonates who are 28-34 weeks in gestation. Exclusion criteria include: significant cardiovascular and respiratory disease, IVH, NEC, on opioids or sedatives. After obtaining parental consent, subjects were randomly assigned to receive standard of care (control, n=12) or either 24% oral sucrose (n=14) or 30% oral glucose (n=13) two minutes before any tissue-damaging procedure (TDP). Demographic data for categorical variables were analyzed using Chi-square test. Repeated measures ANOVA for one between subject factor (group) and one within subject factor (time) were assessed to evaluate the effect of the procedures (control, 24% oral sucrose, 30% oral glucose) over time. Interaction terms in the General Linear Model were used for this purpose.
Results: We found that neonates who received 24% oral sucrose tend to have higher urinary concentration of xanthine compared to those who received 30% oral glucose, specifically at day of life 4. However, the highest urinary concentrations of xanthine (P=0.019) and uric acid (P=0.028) were found in control subjects who received the least amount of oral sucrose analgesia.
Conclusion: These data support our previous findings that untreated pain results in increased ATP utilization and oxidative stress [2]. In addition, this finding suggests that 30% oral glucose may be an acceptable and metabolically less demanding alternative to oral sucrose as a non-pharmacological intervention to procedural pain. Further studies are required to examine more effective ways to decrease procedural pain in preterm neonates.
Sigma Membership
Non-member
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Biochemical Markers, Neonate, Procedural Pain
Recommended Citation
Angeles, Danilyn Mag-akat and Boskovic, Danilo, "Untreated procedural pain increases urine markers of adenosine triphosphate (ATP) utilization in preterm neonates" (2017). INRC (Congress). 116.
https://www.sigmarepository.org/inrc/2017/presentations_2017/116
Conference Name
28th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Dublin, Ireland
Conference Year
2017
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Untreated procedural pain increases urine markers of adenosine triphosphate (ATP) utilization in preterm neonates
Dublin, Ireland
Purpose: We previously published that a single dose of oral sucrose significantly increased plasma markers of adenosine triphosphate (ATP) utilization (hypoxanthine) and oxidative stress (xanthine, allantoin) in neonates undergoing a clinically required heel lance [1,2]. However, the effect of repeated doses of sucrose and other sweet solutions such as glucose on above markers is unknown.
Methods: Using a prospective randomized double blind clinical trial, we measured urinary markers of ATP utilization and oxidative stress in preterm neonates over days of life 3-7. Subjects were preterm neonates who are 28-34 weeks in gestation. Exclusion criteria include: significant cardiovascular and respiratory disease, IVH, NEC, on opioids or sedatives. After obtaining parental consent, subjects were randomly assigned to receive standard of care (control, n=12) or either 24% oral sucrose (n=14) or 30% oral glucose (n=13) two minutes before any tissue-damaging procedure (TDP). Demographic data for categorical variables were analyzed using Chi-square test. Repeated measures ANOVA for one between subject factor (group) and one within subject factor (time) were assessed to evaluate the effect of the procedures (control, 24% oral sucrose, 30% oral glucose) over time. Interaction terms in the General Linear Model were used for this purpose.
Results: We found that neonates who received 24% oral sucrose tend to have higher urinary concentration of xanthine compared to those who received 30% oral glucose, specifically at day of life 4. However, the highest urinary concentrations of xanthine (P=0.019) and uric acid (P=0.028) were found in control subjects who received the least amount of oral sucrose analgesia.
Conclusion: These data support our previous findings that untreated pain results in increased ATP utilization and oxidative stress [2]. In addition, this finding suggests that 30% oral glucose may be an acceptable and metabolically less demanding alternative to oral sucrose as a non-pharmacological intervention to procedural pain. Further studies are required to examine more effective ways to decrease procedural pain in preterm neonates.